Herantis Pharma Plc | Press Release | August 14, 2023 at 13:00:00 EEST
Herantis Pharma Plc, Press Release, August 14 2023, at 13:00 EEST
Herantis Pharma Plc (“Herantis”), a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease, today announced that the company will release 1H 2023 Report on Thursday, August 24, 2023, at 08:00 EEST/ 07:00 CEST.
Members of the Herantis’ Management team will hold a live webinar to provide more details on the 1H 2023 Report with a live Q&A session (in English) for investors, analysts, and media at 10:00 EEST / 9:00 CEST on the same date.
Please join the webinar a few minutes in advance.
Registration details: Herantis’ 1H 2023 Report Webinar
Registration is required for this event. To register for this event, you need a Zoom account. After registering, you will receive a confirmation email containing information about joining the webinar.
Questions can be submitted throughout the webcast event.
Following the webcast of the live call, a recording will be available on Herantis Pharma’s website: https://herantis.com/news-events/video-presentations/